Why Ocugen Trounced the Market on Thursday

Ocugen (NASDAQ: OCGN) was a standout stock in the healthcare realm on Thursday, with its share price shooting more than 10% higher, against the slight decline of the S&P 500 index. The gene therapies specialist benefited from some encouraging news from a business partner.

These days, big movements in Ocugen's stock are tied to Covaxin, the coronavirus vaccine for which it holds the exclusive commercial rights in the U.S.

Image source: Getty Images.

Continue reading

Source Fool.com